Shionogi To Invest In New Research Facility And Consolidate Kansai Bases
This article was originally published in PharmAsia News
Executive Summary
Shionogi announced Jan. 28 plans to invest ¥14 billion toward building a new research facility in Fuchu, Osaka. Shionogi will consolidate its three research facilities currently spread throughout the Kansai area - Osaka City, Setsu City and Kouka City - and move around 700 researchers into the new facility, in which drug development and safety research will be conducted. The new facility is scheduled to begin operation in summer 2010. Takeda, another Osaka-based pharmaceutical giant, has set up a new research institute in Kanagawa prefecture. (Click here for more-Japanese language